Try our Advanced Search for more refined results
Ferring Pharmaceuticals
-
Misc | Filed: May 16, 2024 | Entered: May 16, 2024 Ferring Pharmaceuticals Inc. et al v. Finch Therapeutics Group, Inc. et al
Patent | Delaware
Letter
Letter to The Honorable Sherry R. Fallon from Mary W. Bourke regarding response to Section II of Finch/UMN's discovery dispute letter - re 338 Letter. (Bourke, Mary)
-
Misc | Filed: May 16, 2024 | Entered: May 16, 2024 Ferring Pharmaceuticals Inc. et al v. Finch Therapeutics Group, Inc. et al
Patent | Delaware
- Transcript
Official Transcript of Discovery Dispute held on 02-08-2024 before Judge Hall. Court Reporter Stacy Ingram,Email: stacy_ingram@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 6/6/2024. Redacted Transcript Deadline set for 6/17/2024. Release of Transcript Restriction set for 8/14/2024. (Ingram, Stacy)
-
Misc | Filed: May 16, 2024 | Entered: May 16, 2024 Ferring Pharmaceuticals Inc. et al v. Finch Therapeutics Group, Inc. et al
Patent | Delaware
Letter
[SEALED] Letter to The Honorable Jennifer L. Hall from Kelly E. Farnan regarding Opposition to Ferring's Motion to Amend and Motion to Supplement - re 337 Letter,. (Attachments: # 1 Exhibit A-B)(Farnan, Kelly)
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Archive of over 450,000 articles
- Database of over 2.1 million cases
- 62,000+ organization-specific pages.
- Daily and real-time news and case alerts on organizations, industries, and customized search queries.
- Significant legal events involving law firms, companies, industries, and government agencies.
- Learn more
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login